104 related articles for article (PubMed ID: 1898429)
1. Preparation of iodine labeled recombinant human erythropoietin.
Kinoshita H; Ohishi N; Okazaki A
Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
[TBL] [Abstract][Full Text] [Related]
3. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.
Kinoshita H; Ohishi N; Tokura S; Okazaki A
Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of erythropoietin in genetically anemic mice.
Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of erythropoietin in intact and anephric dogs.
Fu JS; Lertora JJ; Brookins J; Rice JC; Fisher JW
J Lab Clin Med; 1988 Jun; 111(6):669-76. PubMed ID: 3373111
[TBL] [Abstract][Full Text] [Related]
8. Biological characterization of recombinant human erythropoietin.
Krumwieh D; Arnold I; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):193-201. PubMed ID: 3240225
[TBL] [Abstract][Full Text] [Related]
9. Sexual dimorphism of erythropoietin-degrading activity in mouse submaxillary gland extracts.
Tam RC; Bedwell J; Cotes PM; Reed PJ
Exp Hematol; 1989 Feb; 17(2):160-3. PubMed ID: 2912738
[TBL] [Abstract][Full Text] [Related]
10. Damage of tracer erythropoietin results in erroneous estimation of concentration in mouse submaxillary gland.
Vidal A; Carcagno M; Criscuolo M; Barcelò AC; Alippi RM; Leal T; Bozzini CE
Exp Hematol; 1993 Feb; 21(2):299-302. PubMed ID: 8425566
[TBL] [Abstract][Full Text] [Related]
11. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
[TBL] [Abstract][Full Text] [Related]
12. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies.
Widness JA; Schmidt RL; Veng-Pedersen P; Modi NB; Sawyer ST
J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741
[TBL] [Abstract][Full Text] [Related]
13. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
[TBL] [Abstract][Full Text] [Related]
14. [The preparation and identification of anti-erythropoietin monoclonal antibodies].
Jiang M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):138-42. PubMed ID: 8242822
[TBL] [Abstract][Full Text] [Related]
15. Ligand binding kinetics of a soluble full-length murine erythropoietin receptor.
Avedissian LS; Poola I; Spivak JL
Biochem Biophys Res Commun; 1995 Nov; 216(1):62-8. PubMed ID: 7488125
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin.
Kobayashi H; Kao CH; Kreitman RJ; Le N; Kim MK; Brechbiel MW; Paik CH; Pastan I; Carrasquillo JA
J Nucl Med; 2000 Apr; 41(4):755-62. PubMed ID: 10768579
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R
Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532
[TBL] [Abstract][Full Text] [Related]
18. Immunological response to repeated administration of recombinant human erythropoietin in rats: biphasic effect on its pharmacokinetics.
Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
Drug Metab Dispos; 1997 Sep; 25(9):1039-44. PubMed ID: 9311618
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of erythropoietin receptors on normal human bone marrow cells.
Hoshino S; Teramura M; Takahashi M; Motoji T; Oshimi K; Ueda M; Mizoguchi H
Int J Cell Cloning; 1989 May; 7(3):156-67. PubMed ID: 2543713
[TBL] [Abstract][Full Text] [Related]
20. Purification of biologically active human erythropoietin-binding protein and detection of its binding sites.
Lee JY
Ann Clin Lab Sci; 2007; 37(1):63-70. PubMed ID: 17311871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
